Related Experiment Video

Updated: Aug 6, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone

Douglas R Hurst1, Alka Mehta, Blake P Moore

  • 1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.

Biochemical and Biophysical Research Communications
|August 22, 2006
PubMed

Insights

Breast cancer metastasis suppressor 1 (BRMS1) interacts with chaperones like Hsp90 and HDACs. Hsp90 stabilizes BRMS1, suggesting protein stability is key for its metastasis suppression role.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Breast cancer metastasis suppressor 1 (BRMS1) is a key component of the mSin3-HDAC transcriptional co-repressor complex.
  • The full spectrum of proteins interacting with BRMS1 remains incompletely characterized.
  • Understanding BRMS1 interactions is crucial for elucidating its role in metastasis suppression.

Purpose of the Study:

  • To identify novel proteins that interact with Breast cancer metastasis suppressor 1 (BRMS1).
  • To investigate the relationship between BRMS1, heat shock proteins (Hsp90, Hsp70), and histone deacetylases (HDACs).
  • To determine the factors regulating BRMS1 protein stability.

Main Methods:

  • Yeast two-hybrid screening to identify potential interacting partners.
  • Immuno-affinity chromatography to isolate BRMS1-associated proteins.
  • Co-immunoprecipitation assays to confirm protein-protein interactions.
  • Analysis of BRMS1 stability and proteasomal degradation pathways.

Main Results:

  • Identified novel BRMS1-interacting proteins (BIPs), including chaperones DNAJB6 (MRJ), Hsp90, and Hsp70.
  • Confirmed interactions between BRMS1 and class II HDACs (HDAC4, HDAC5, HDAC6).
  • Demonstrated that Hsp90 stabilizes BRMS1, and its degradation is proteasome-dependent.

Conclusions:

  • BRMS1 engages with a network of chaperones and HDACs, expanding its known functional complex.
  • Hsp90-mediated stabilization of BRMS1 is a critical factor for its function.
  • The stability of BRMS1 protein is essential for its efficacy in suppressing cancer metastasis.

More Related Videos

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...